Treatment for Breast Cancer

Phase-Based Progress Estimates
University of Hawaii Cancer Center, Honolulu, HI
Breast Cancer+1 More
Eligible conditions

Study Summary

This study is evaluating whether exercise can help improve body composition for breast cancer patients.

See full description

Eligible Conditions

  • Breast Cancer

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 11 primary outcomes and 7 secondary outcomes in patients with Breast Cancer. Measurement will happen over the course of 1 day.

1 day
Automatic 3D optical (3DO) scan measurement: girth measurement
Automatic 3D optical (3DO) scan measurement: length measurement
Automatic 3D optical (3DO) scan measurement: volume measurement
Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data
Bone mass
Fat mass
Isometric peak torque
Lean mass
Muscle Function
Percent fat
Waist to Hip ratio (WHR) from manual tape measurement
5 years
BFI-Brief Fatigue Innovatory questionnaire
BIBCQ-Body Image After Breast Cancer questionnaire
Diet History Questionnaire II
FACT-G-Functional Assessment of Cancer Therapy-General (Comorbidities)questionnaire
PHQ-9- Patient Health (Depression) questionnaire
Recurrence Free Survival

Trial Safety

Safety Estimate

1 of 3

Trial Design

2 Treatment Groups

Group 2 - Declines Exercise Program
1 of 2
Group 1 - Agree to Exercise Program
1 of 2
Active Control

This trial requires 165 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Group 2 - Declines Exercise ProgramSame biometric and biomarker assessment at as Group 1 (at baseline, after 12 weeks and annually) however they will not participate in the exercise sessions
Group 1 - Agree to Exercise Program
12-week exercise program

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 5 years for reporting.

Closest Location

University of Hawaii Cancer Center - Honolulu, HI

Eligibility Criteria

This trial is for female patients aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
The text states that a person has been diagnosed with breast cancer within the past 2 years, and that it is any subtype, stage I-III. show original
They may be undergoing neo/adjuvant treatment (surgery, chemotherapy, radiation or endocrine therapy). show original
The participant is willing and able to comply with the study protocol for the duration of the study, including attending all scheduled exercise sessions, completing questionnaires, and participating in biometric/biomarker studies. show original
The participant must be able to stand without aid for at least 2 minutes. show original
The participant must be able to lie flat on their back for up to 10 minutes. show original

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Breast Cancer by sharing your contact details with the study coordinator.